» Articles » PMID: 23882270

Regulation of Hematopoietic Stem Cell Activity by Inflammation

Overview
Journal Front Immunol
Date 2013 Jul 25
PMID 23882270
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cells (HSCs) are quiescent cells with self-renewal capacity and the ability to generate all mature blood cells. HSCs normally reside in specialized niches in the bone marrow that help maintain their quiescence and long-term repopulating activity. There is emerging evidence that certain cytokines induced during inflammation have significant effects on HSCs in the bone marrow. Type I and II interferons, tumor necrosis factor, and lipopolysaccharide (LPS) directly stimulate HSC proliferation and differentiation, thereby increasing the short-term output of mature effector leukocytes. However, chronic inflammatory cytokine signaling can lead to HSC exhaustion and may contribute the development of hematopoietic malignancies. Pro-inflammatory cytokines such as G-CSF can also indirectly affect HSCs by altering the bone marrow microenvironment, disrupting the stem cell niche, and leading to HSC mobilization into the blood. Herein, we review our current understanding of the effects of inflammatory mediators on HSCs, and we discuss the potential clinical implications of these findings with respect to bone marrow failure and leukemogenesis.

Citing Articles

Stem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation - a virtual clinical trial.

Stiehl T Front Immunol. 2024; 15:1321336.

PMID: 39737169 PMC: 11682905. DOI: 10.3389/fimmu.2024.1321336.


A Review of Key Regulators of Steady-State and Ineffective Erythropoiesis.

Tichil I, Mitre I, Zdrenghea M, Bojan A, Tomuleasa C, Cenariu D J Clin Med. 2024; 13(9).

PMID: 38731114 PMC: 11084473. DOI: 10.3390/jcm13092585.


Aging brain: exploring the interplay between bone marrow aging, immunosenescence, and neuroinflammation.

Muller L, Di Benedetto S Front Immunol. 2024; 15:1393324.

PMID: 38638424 PMC: 11024322. DOI: 10.3389/fimmu.2024.1393324.


Inflammatory auxo-action in the stem cell division theory of cancer.

Luo Y, Xiao J PeerJ. 2023; 11:e15444.

PMID: 37309372 PMC: 10257902. DOI: 10.7717/peerj.15444.


Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation.

Muto T, Walker C, Agarwal P, Vick E, Sampson A, Choi K Haematologica. 2023; 108(10):2715-2729.

PMID: 37102608 PMC: 10542836. DOI: 10.3324/haematol.2022.282349.


References
1.
Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View

2.
Papadaki H, Kritikos H, Valatas V, Boumpas D, Eliopoulos G . Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood. 2002; 100(2):474-82. DOI: 10.1182/blood-2002-01-0136. View

3.
Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M . Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia. 1998; 11(12):2049-54. DOI: 10.1038/sj.leu.2400844. View

4.
Megias J, Yanez A, Moriano S, OConnor J, Gozalbo D, Gil M . Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages. Stem Cells. 2012; 30(7):1486-95. DOI: 10.1002/stem.1110. View

5.
Baldridge M, King K, Boles N, Weksberg D, Goodell M . Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature. 2010; 465(7299):793-7. PMC: 2935898. DOI: 10.1038/nature09135. View